• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高 CHA(2)DS(2)-VASc 评分与外周动脉阻塞性疾病患者发生严重肢体缺血的风险增加相关。

A high CHA(2)DS(2)-VASc score is associated with a high risk for critical limb ischemia in peripheral arterial occlusive disease patients.

机构信息

Department of Internal Medicine, Division of Angiology, Medical University Graz, Auenbruggerplatz 15, 8036 Graz, Austria.

出版信息

Atherosclerosis. 2012 Dec;225(2):517-20. doi: 10.1016/j.atherosclerosis.2012.10.025. Epub 2012 Oct 11.

DOI:10.1016/j.atherosclerosis.2012.10.025
PMID:23102450
Abstract

BACKGROUND

The CHA(2)DS(2)-VASc (congestive heart failure, hypertension, age ≥ 75 years (doubled), type 2 diabetes, previous stroke, transient ischemic attack, or thromboembolism (doubled), vascular disease, age 65-75 years, and sex category) score was published as a predictive scoring model for stroke in atrial fibrillation patients. As multiple vascular risk factors are included in this score we evaluated the occurrence of critical limb ischemia (CLI) in peripheral arterial occlusive disease (PAOD) patients according to their CHA(2)DS(2)-VASc score independent of a coexisting atrial fibrillation.

METHODS

We evaluated 2237 PAOD patients treated at our institution from 2005 to 2010. CHA(2)DS(2)-VASc score was calculated and the occurrence of CLI was investigated. Furthermore all constituents of the score were investigated concerning association with CLI.

RESULTS

Frequency of CLI was higher in patients with a high CHA(2)DS(2)-VASc score. Age ≥ 75 years was associated with an increased risk for CLI (OR 3.0), as was age 65-75 years (OR 1.8), type 2 diabetes (OR 2.8), and the factor previous stroke, transient ischemic attack, or thromboembolism (OR 1.4). The occurrence of arterial hypertension was protective for CLI (OR 0.6). Sex and congestive heart failure were not associated with an increased CLI risk.

CONCLUSION

High CHA(2)DS(2)-VASc score is associated with a high CLI risk. As not all constituents are equally associated with CLI and some are even protective, a new score including only some of the factors should be evaluated for the prediction of CLI.

摘要

背景

CHA(2)DS(2)-VASc(充血性心力衰竭、高血压、年龄≥75 岁(加倍)、2 型糖尿病、既往卒中、短暂性脑缺血发作或血栓栓塞(加倍)、血管疾病、65-75 岁和性别类别)评分被公布为预测房颤患者中风的评分模型。由于该评分包含多个血管危险因素,因此我们评估了外周动脉闭塞性疾病(PAOD)患者根据其 CHA(2)DS(2)-VASc 评分发生严重肢体缺血(CLI)的情况,而不考虑同时存在的房颤。

方法

我们评估了 2005 年至 2010 年在我们机构治疗的 2237 例 PAOD 患者。计算了 CHA(2)DS(2)-VASc 评分,并研究了 CLI 的发生情况。此外,还研究了评分的所有成分与 CLI 的关系。

结果

CHA(2)DS(2)-VASc 评分高的患者 CLI 发生率较高。年龄≥75 岁与 CLI 风险增加相关(OR 3.0),65-75 岁年龄(OR 1.8)、2 型糖尿病(OR 2.8)和既往卒中、短暂性脑缺血发作或血栓栓塞(OR 1.4)也是如此。动脉高血压的发生对 CLI 有保护作用(OR 0.6)。性别和充血性心力衰竭与 CLI 风险增加无关。

结论

高 CHA(2)DS(2)-VASc 评分与 CLI 风险增加相关。由于并非所有成分都与 CLI 同等相关,有些成分甚至具有保护作用,因此应该评估仅包括部分因素的新评分以预测 CLI。

相似文献

1
A high CHA(2)DS(2)-VASc score is associated with a high risk for critical limb ischemia in peripheral arterial occlusive disease patients.高 CHA(2)DS(2)-VASc 评分与外周动脉阻塞性疾病患者发生严重肢体缺血的风险增加相关。
Atherosclerosis. 2012 Dec;225(2):517-20. doi: 10.1016/j.atherosclerosis.2012.10.025. Epub 2012 Oct 11.
2
Reliable identification of "truly low" thromboembolic risk in patients initially diagnosed with "lone" atrial fibrillation: the Belgrade atrial fibrillation study.可靠识别最初诊断为“孤立”心房颤动患者中的“真正低”血栓栓塞风险:贝尔格莱德心房颤动研究。
Circ Arrhythm Electrophysiol. 2012 Apr;5(2):319-26. doi: 10.1161/CIRCEP.111.966713. Epub 2012 Feb 8.
3
Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study.基于社区队列研究的 CHA2DS2-VASc 评分为 0 的心房颤动患者的预后。
J Cardiovasc Electrophysiol. 2012 Jul;23(7):708-13. doi: 10.1111/j.1540-8167.2011.02257.x. Epub 2012 Jan 23.
4
Comparison between CHADS2 and CHA2 DS2 -VASc score in a stroke cohort with atrial fibrillation.房颤脑卒中患者中 CHADS2 评分与 CHA2DS2-VASc 评分的比较。
Eur J Neurol. 2013 Apr;20(4):623-8. doi: 10.1111/j.1468-1331.2012.03807.x. Epub 2012 Jul 27.
5
The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.在接受抗凝治疗的房颤患者中,HAS-BLED 评分对大出血的预测准确性优于 CHADS2 或 CHA2DS2-VASc 评分。
J Am Coll Cardiol. 2013 Dec 10;62(23):2199-204. doi: 10.1016/j.jacc.2013.08.1623. Epub 2013 Sep 18.
6
CHADS2 and CHA2DS2-VASc risk factors to predict first cardiovascular hospitalization among atrial fibrillation/atrial flutter patients.CHADS2 和 CHA2DS2-VASc 风险因素预测心房颤动/心房扑动患者首次心血管住院事件。
Am J Cardiol. 2012 May 15;109(10):1526-33. doi: 10.1016/j.amjcard.2012.01.371. Epub 2012 Feb 22.
7
CHADS-VASc Score (Congestive Heart Failure, Hypertension, Age ≥75 [Doubled], Diabetes Mellitus, Prior Stroke or Transient Ischemic Attack [Doubled], Vascular Disease, Age 65-74, Female) for Stroke in Asian Patients With Atrial Fibrillation: A Korean Nationwide Sample Cohort Study.亚洲房颤患者卒中的CHADS-VASc评分(充血性心力衰竭、高血压、年龄≥75岁[加倍]、糖尿病、既往卒中或短暂性脑缺血发作[加倍]、血管疾病、年龄65 - 74岁、女性):一项韩国全国性样本队列研究。
Stroke. 2017 Jun;48(6):1524-1530. doi: 10.1161/STROKEAHA.117.016926. Epub 2017 Apr 28.
8
Epidemiology of peripheral arterial disease and critical limb ischemia in an insured national population.参保全国人口中周围动脉疾病和严重肢体缺血的流行病学
J Vasc Surg. 2014 Sep;60(3):686-95.e2. doi: 10.1016/j.jvs.2014.03.290. Epub 2014 May 10.
9
Usefulness of transesophageal echocardiography to confirm clinical utility of CHA2DS2-VASc and CHADS2 scores in atrial flutter.经食管超声心动图在确认 CHA2DS2-VASc 和 CHADS2 评分在心房扑动中的临床实用性中的作用。
Am J Cardiol. 2012 Feb 15;109(4):550-5. doi: 10.1016/j.amjcard.2011.10.007. Epub 2011 Nov 29.
10
Predictive value of the CHA2DS2-VASc score in atrial fibrillation patients at high risk for stroke despite oral anticoagulation.尽管接受了口服抗凝治疗,但CHA2DS2-VASc评分对房颤高危卒中患者的预测价值。
Rev Esp Cardiol (Engl Ed). 2012 Jul;65(7):627-33. doi: 10.1016/j.recesp.2012.02.017. Epub 2012 May 18.

引用本文的文献

1
Assessing the Suitability of CHADS-VASc for Predicting Adverse Limb Events and Cardiovascular Outcomes in Peripheral Artery Disease Patients with Percutaneous Transluminal Angioplasty: A Retrospective Cohort Study.评估CHADS-VASc评分对预测接受经皮腔内血管成形术的外周动脉疾病患者肢体不良事件和心血管结局的适用性:一项回顾性队列研究。
Biomedicines. 2024 Jun 20;12(6):1374. doi: 10.3390/biomedicines12061374.
2
The AST/ALT (De-Ritis) ratio: A novel marker for critical limb ischemia in peripheral arterial occlusive disease patients.谷草转氨酶/谷丙转氨酶(德瑞蒂斯)比值:外周动脉闭塞性疾病患者严重肢体缺血的一种新型标志物。
Medicine (Baltimore). 2016 Jun;95(24):e3843. doi: 10.1097/MD.0000000000003843.
3
Graz Critical Limb Ischemia Score: A Risk Score for Critical Limb Ischemia in Peripheral Arterial Occlusive Disease.
格拉茨严重肢体缺血评分:外周动脉闭塞性疾病中严重肢体缺血的风险评分
Medicine (Baltimore). 2015 Jul;94(27):e1054. doi: 10.1097/MD.0000000000001054.
4
Platelet-to-lymphocyte ratio: a novel marker for critical limb ischemia in peripheral arterial occlusive disease patients.血小板与淋巴细胞比值:外周动脉闭塞性疾病患者肢体严重缺血的新标志物。
PLoS One. 2013 Jul 2;8(7):e67688. doi: 10.1371/journal.pone.0067688. Print 2013.
5
Neutrophil-to-lymphocyte ratio and its association with critical limb ischemia in PAOD patients.中性粒细胞与淋巴细胞比值及其与 PAOD 患者肢体严重缺血的关系。
PLoS One. 2013;8(2):e56745. doi: 10.1371/journal.pone.0056745. Epub 2013 Feb 15.